Quadrant Capital Group’s AbCellera Biologics ABCL Stock Holding History

Quadrant Capital Group’s Portfolio ABCL Stock Details ABCL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$7.19K	Buy
2025 Q2	–	Sell
2025 Q1	$48.9K	Sell
2024 Q4	$160K	Buy
2024 Q3	$77.6K	Buy
2024 Q2	$3.11K	Buy
2024 Q1	$2.03K	Sell
2023 Q4	$11.4K	Buy
2023 Q3	$4.06K	Hold
2023 Q2	$5.7K	Buy